![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 18611-18618, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, November 12, 2001, and in revised form, March 6, 2002
Azidothymidine (AZT) is a widely used inhibitor
of type 1 human immunodeficiency virus reverse transcriptase
(RT) that acts as chain terminator. Upon treatment, mutations
conferring AZT resistance to RT are gradually selected. It has been
shown that resistant RT is able to unblock the AZT-terminated primer by
an ATP-dependent mechanism. However, this resistance
mechanism has only been demonstrated for DNA-dependent DNA
elongation. Here, we compared the AZT resistance of mutant RT during
DNA elongation on DNA and RNA templates. We showed that, during DNA
elongation, primer unblocking and rescue of DNA synthesis take place
with similar rate constants on DNA and RNA templates. However, the fraction of a primer eventually repaired during
RNA-dependent DNA synthesis is 2× lower compared with that
of DNA-dependent synthesis, leading to reduced resistance.
We also compared the initiation of reverse transcription, which uses
tRNA The introduction of highly active antiretroviral
treatments against the type 1 human immunodeficiency virus
(HIV-1)1 dramatically
decreased the mortality linked to AIDS in developed countries (1).
Highly active antiretroviral treatments usually combine inhibitors of
the viral protease, which is required for maturation of the viral
particles, with inhibitors of reverse transcriptase (RT), which
converts the single stranded RNA genome into double-stranded DNA (2).
The reverse transcriptase inhibitors are either deoxyribonucleoside
analogs (NRTIs) that act as chain terminators or non-nucleotide
inhibitors (NNRTIs) that bind to a hydrophobic pocket next to the RT
catalytic site (for a review, see Ref. 3). In addition to the high cost
that makes them unavailable in developing countries, the efficiency of
highly active antiretroviral treatments is limited by long term adverse
side effects and the rapid emergence of multiresistant HIV-1 strains
(2).
AZT (3'-azido-3'-deoxythymidine), a nucleoside reverse transcriptase
inhibitor, was the first drug approved by the Food and Drug
Administration for the treatment of AIDS and is still widely used in
combination with other antiretroviral drugs (2). The prolonged clinical
use of AZT gives rise to resistant viruses that usually contain the
mutations M41L, D67N, K70R, T215(Y/F), and K219Q in their RT (4-6).
In vivo, these mutations provide a 100-200-fold resistance
toward AZT (4-7). However, the mechanism of resistance to AZTTP, the
active form of AZT (8), remained unclear until recently. Indeed,
AZT-resistant RT incorporates AZT as efficiently as the wild type (wt)
polymerase (9-12). This situation contrasts with the enzymes that bear
the mutations K65R (13, 14), L74V (15), and M184V (16-18) and that
confer resistance toward ddC, ddI, and 3TC, respectively.
Recently, several lines of evidence indicated that resistance toward
AZTTP is due to the increased unblocking of the AZT-terminated primer,
rendering chain termination reversible (Fig. 1A). First, resistant RT was shown to bind AZT-terminated primers more tightly than
wt RT does (19). Secondly, it was reported that resistant RT has an
increased pyrophosphorolysis rate (20, 21), but this observation was
not confirmed by other groups (9, 22). Finally, it was shown that the
AZT-resistant enzyme, unlike wt RT, could efficiently unblock
AZT-terminated primers using ATP instead of PPi in a
reaction analogous to pyrophosphorolysis (21-23) (Fig. 1A).
However, all ATP lysis experiments performed so far used DNA/DNA
primer-template complexes.
The high overall resistance provided by the M41L, D67N, K70R,
T215(Y/F), and K219Q mutations suggests that primer unblocking also
works efficiently on DNA/RNA primer-template complexes. However, the
relative resistance toward AZT during synthesis of the ( In addition, our studies of the initiation of HIV-1 reverse
transcription, which corresponds to the addition of the first six
nucleotides to the tRNA To address these points, we first compared ATP lysis of a primer
terminal AZT during (+) strand and ( Template, Primers, and RT--
Natural
tRNA
The template strand was either an RNA encompassing nucleotides 1-311
(RNA-(1-311)) or 159-196 (RNA-(159-196)) of the HIV-1 Mal genomic
RNA or a DNA corresponding to nucleotides 159-196 (DNA-(159-196)) of
the same isolate. All templates contained the PBS (nucleotides
179-196). RNA-(1-311) was obtained by in vitro transcription as described (34), whereas RNA-(159-196) and
DNA-(159-196) were chemically synthesized. Wild type RT and the
resistant RT-bearing mutations D67N, K70R, T215F, and K219K were
purified as previously described (20).
Primer Unblocking--
2-5 nM labeled
tRNA Rescue of DNA Synthesis--
Kinetics were performed as above,
except that the reaction was initiated by the addition of 50 µM dTTP, 50 µM ddGTP, 3.5 mM ATP, and 0.005 units/µl inorganic pyrophosphatase (Sigma).
All ATP lysis experiments using AZT-resistant RT published to date
were performed using DNA/DNA primer-template complexes (21-23,36).
However, the efficiency of this reaction, like other properties of
HIV-1 RT, might vary considerably during the different steps of the
provirus synthesis. Because provirus synthesis requires both RNA- and
DNA-dependent DNA elongation, we first compared the
efficiency of the excision reaction during synthesis of the (+) and
( Because ATP lysis is sensitive to the presence of the next incoming
nucleotide (22, 36), two series of experiments were performed. In the
first one, the excision reaction was performed in the absence of any
nucleoside triphosphate, and we monitored the appearance of a product
one nucleotide shorter than the initial primer. In the second, the
reaction was performed in the presence of dTTP and ddGTP. After removal
of the terminal AZT, these two nucleotides could be incorporated (Fig.
1B), and we followed the rescue of DNA synthesis, which
generated products extended by one nucleotide, as compared with the
primer. In all experiments, the AZT-resistant RT was compared with the
wt enzyme, and reactions were conducted in the absence and in the
presence of ATP (3.5 mM).
Comparison of AZT Excision and the Rescue of DNA Synthesis during
DNA- and RNA-dependent DNA Elongation
Excision of the Terminal AZT--
When ODN-dC-AZT was annealed to
the DNA-(159-196) template, excision of the terminal AZT in the
presence of 3.5 mM ATP could be observed with both the wt
and the resistant RT (Fig.
2A). However, the reaction was
much more efficient with resistant RT, as confirmed by quantitative
analysis of the data. Both reactions followed a first order kinetics
(Fig. 2B), excision being 4-fold faster with resistant RT
(kexc = 1.38 × 10
When we used RNA-(159-196) as a template, fast AZT excision was
observed in the presence of 3.5 mM ATP with the
AZT-resistant RT (Fig. 2C). Indeed, the excision rate
deduced from the fit of the experimental data to a single exponential
(2.1 × 10
Incomplete annealing of the primer to the RNA template could be a
trivial explanation for the different amplitudes of the AZT excision
from ODN-dC-AZT annealed either to DNA-(159-196) or RNA-(159-196). To
test this possibility, the primer-template complexes were analyzed by
electrophoresis through a non-denaturing polyacrylamide gel (Fig.
2E). The autoradiography of the gel showed complete
annealing of ODN-dC-AZT to RNA-(159-196) (Fig. 2E,
lane 2), whereas >95% of the primer was bound to
DNA-(159-196). In the latter case, the slightly retarded migration of
the unbound primer as compared with free ODN-dC-AZT (compare
lanes 1 and 3) and the smear between
the two bands suggested that annealing was essentially complete and
that a small fraction of the complex dissociated during
electrophoresis. These controls clearly showed that the different
amplitudes of the excision reactions were not due to incomplete
annealing of the primer to RNA-(159-196).
Rescue of DNA Synthesis--
With the DNA-(159-196) template, an
efficient rescue of DNA synthesis in the presence of dTTP and ddGTP was
observed with resistant RT when ATP was included in the reaction (Fig.
3A). A quantitative analysis
of the rescue kinetics showed that the amplitude of this reaction
(75%) is in keeping with that of the excision reaction (compare Figs.
2B and 3D). However, the rate of DNA synthesis
rescue (kresc = 4.2 × 10
Similar results were obtained when using RNA-(159-196) as a template
(Fig. 3, B and D). An efficient rescue of DNA
synthesis by resistant RT was observed in the presence of 3.5 mM ATP. Its rate, 6.4 × 10 AZT Excision and Rescue of DNA Synthesis during the Initiation of
( We showed previously that terminal dT and AZT could be removed
with similar efficiencies from the primer by wt RT via
pyrophosphorolysis during the elongation of ( The similarity between pyrophosphorolysis and ATP lysis (22, 23, 32)
prompted us to test whether AZT could be excised by resistant RT via
ATP lysis during the initiation of reverse transcription. Because
optimal initiation of ( As a first control, we compared the rescue of DNA synthesis using
ODN-dC-AZT as the primer and RNA-(1-311) as the template with the one
obtained under the same conditions with RNA-(159-196) as the template
(Fig. 3, C and D). The amplitude of the reaction and its rate (6.9 × 10 We next studied the rescue of DNA synthesis from
tRNA
Primer Unblocking and Rescue of DNA Synthesis by Azidothymidine
(AZT)-resistant HIV-1 Reverse Transcriptase
COMPARISON BETWEEN INITIATION AND ELONGATION OF REVERSE
TRANSCRIPTION AND BETWEEN (
) AND (+) STRAND DNA SYNTHESIS*
,
,
, and
Unité Propre de Recherche
9002 du CNRS, Institut de Biologie Moléculaire et Cellulaire,
15 rue René Descartes, 67084 Strasbourg cedex, France and the
§ Jewish General Hospital, Lady Davis Institute for
Medical Research, Montréal, Quebec H3T 1E2, Canada
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

) DNA strand synthesis. Our results demonstrate that
the efficiency of primer unblocking conferred by the AZT resistance
mutations greatly vary during the different steps of the provirus
synthesis. These results also suggest that inhibitors specifically targeting the initiation of reverse transcription might
prove to be advantageous, as compared with elongation
inhibitors.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) and (+)
proviral DNA strands is presently unknown. Several properties of the
HIV-1 RT, such as the polymerization rate (24), processivity (24), and
fidelity (25), significantly differ on DNA and RNA templates. Thus, the
efficiency of primer unblocking by the resistant RT might also
considerably differ during synthesis of the (
) and (+) proviral DNA strands.


) strand DNA
synthesis. Indeed, during initiation the removal of AZT was hardly
detectable at all (31). Given the strong similarity between PPi- and ATP-mediated primer unblocking reactions (22, 23, 32), it is conceivable that resistant RT is unable to unblock an
AZT-terminated primer during the initiation of reverse transcription.
) strand DNA synthesis by
AZT-resistant RT. Then, we compared the ATP lysis efficiency during the
initiation and elongation of (
) strand DNA synthesis. We found that
the excision of AZT was less efficient during (
) strand DNA synthesis
as compared with (+) strand DNA synthesis because of an incomplete
reaction. In addition, "AZT-resistant RT" was not resistant toward
AZT during the initiation of reverse transcription. Hence, our results
demonstrate that the efficiency of primer unblocking conferred by the
AZT resistance mutations greatly vary during the different steps of the
provirus synthesis. The results also suggest that inhibitors
specifically targeting the initiation of reverse transcription might be
advantageous as compared with elongation inhibitors.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES






![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) DNA strands. To this aim, we used as a primer ODN-dC-AZT, an
oligodeoxyribonucleotide complementary to the PBS and extended by dC
and AZT, and either a DNA or an RNA template corresponding to
nucleotides 159-196 of HIV-1 Mal (DNA-(159-196) and RNA-(159-196), respectively) (Fig. 1B). In
addition, the excision of AZT from the primer terminus during (
) DNA
strand synthesis was also studied with an RNA template encompassing
nucleotides 1-311 of the same viral isolate (RNA-(1-311)). Using this
template, we then compared the AZT excision from ODN-dC-AZT and
tRNA
) DNA strand
synthesis.

View larger version (29K):
[in a new window]
Fig. 1.
A, incorporation of AZT and mechanisms
of primer unblocking. P and T stand for
primer and template, respectively. After unblocking of the
AZT-terminated primer, DNA synthesis can continue. The incorporation of
dinucleotide tetraphosphates by HIV-1 RT has been demonstrated in Ref.
43. B, primers and templates used in this study. Only part
of HIV-1 RNA-(1-311) is shown. The PBS corresponds to nucleotides 179 to 195 of this RNA. Upper and lowercase
letters stand for ribo- and deoxyribonucleotides,
respectively. Only the 3' sequence of
tRNA 
3 and
3.7 × 10
4 s
1 for resistant and wt RT,
respectively). When no ATP was included in the reaction, no AZT
excision was observed with wt RT, whereas a very limited excision could
be detected when using resistant RT (data not shown).

View larger version (28K):
[in a new window]
Fig. 2.
Unblocking of an AZT-terminated primer during
elongation of (+) and (
) strand DNA synthesis by wt RT and resistant
RTs. A, unblocking of the ODN-dC-AZT·DNA-(159-196)
complex in the presence of 3.5 mM ATP. Lanes
1-22 correspond to increasing reaction times as follows: 0, 6, 12, 18, 24, 30, 36, 42, 48, and 54 s, 1, 2, 3, 4, 5, 7.5, 10, 15, 30, 40, 50, and 60 min, respectively. B, the gels presented in
A were quantified, and the experimental data were fitted to
the equation %ODN
dC
AZT = A·(e
kexct) + C, where A
is the amplitude of the burst, kexc is the
apparent first order rate constant of AZT excision, and C is a
constant. The curves for the wild type (open
circles) and resistant (filled
circles) RTs correspond to kexc = 3.7 × 10
4 ± 5 × 10
5
s
1, 1.38 × 10
3 ± 7 × 10
5 s
1, respectively. C,
unblocking of the ODN-dC-AZT·RNA-(159-196) complex in the presence
of 3.5 mM ATP. Lanes 1-17 correspond to the
following reaction times: 0, 1, 2.5, 5, 7.5, 10, 20, 30, 40, 50, 60,
75, 90, 105, 120, 150, and 180 min, respectively. D,
experimental data obtained by quantifying the gels presented in
C were fitted as in B. The curve for resistant RT
(filled circles) corresponds to
kexc = 2.1 × 10
3 ± 3 × 10
4 s
1. E, analysis of the
primer-template complexes on a non-denaturing 6% polyacrylamide gel.
Labeled ODN-dC-AZT incubated alone (lane 1), and annealed to
RNA-(159-196) (lane 2), DNA-(159-196) (lane 3),
and RNA-(1-311) (lane 4) were compared.
3 s
1) is slightly higher
than that determined using the DNA template (Fig. 2D).
However, the reaction rapidly reached a plateau, and only 40% of the
primer was eventually repaired even after prolonged incubation (up to
3 h, Fig. 2D and data not shown). This situation contrasts with the DNA template, which allowed excision of more than
70% of terminal AZT (Fig. 2B). In addition, using wt RT, the amount of the repaired primer in the presence of ATP was less than
5% with RNA-(159-196) as the template as compared with 50% with
DNA-(159-196) (Fig. 2, B and D). Furthermore, no
excision was observed with the former template in the absence of ATP,
whichever RT we used (data not shown).
4
s
1) (Fig. 3D) is 3-fold lower than the rate of
ATP lysis (Fig. 2B). Because ATP lysis was much slower than
nucleotide addition to the 3'-end of an unblocked primer (30), our
results suggest that ATP lysis was partially inhibited by the next
incoming nucleotide (22, 36). The rescue of DNA synthesis was observed
with the wt RT in the presence of ATP and with resistant RT in its
absence, but these reactions were too weak to allow quantitative
analysis (Fig. 3 and data not shown). No rescue was observed with wt RT in the absence of ATP.

View larger version (28K):
[in a new window]
Fig. 3.
Rescue of DNA synthesis during (
) or (+)
strand synthesis by wt RT and resistant RT.
ODN-dC-AZT/DNA-(159-196) (A), ODN-dC-AZT/RNA-(159-196)
(B), or ODN-dC-AZT/RNA-(1-311) (C)
primer-template complexes were incubated with resistant RT. The rescue
of DNA synthesis was initiated by adding 50 µM dTTP and
50 µM ddGTP. Reactions were conducted in the absence and
in the presence of 3.5 mM ATP; lanes 1-14
correspond to increasing reaction times as follows: 0, 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, and 180 min. respectively.
D, experimental data were fitted to equation %ODN
dC
dT
ddG = A·(1
e
kresct) + C, where A is
the amplitude of the burst and kresc is the
apparent first order rate constant of DNA synthesis rescue. The
kresc values obtained from curve fitting were
kresc(resistant RT, DNA-(159-196)) = 4.2 × 10
4 ± 7 × 10
6
s
1 (filled squares),
kresc(resistant RT, RNA-(159-196)) = 6.4 × 10
4 ± 9 × 10
5
s
1 (open triangles), and
kresc(resistant RT, RNA-(1-311)) = 6.9 × 10
4 ± 1.3 × 10
4 s
1
(filled diamonds).
4
s
1, is close to the one measured for rescue on the DNA
template and 3-fold slower than the excision reaction on the
RNA-(159-196) template, again suggesting that the excision reaction
was somewhat inhibited by the presence of the next incoming nucleotide.
As observed for the excision reaction, the amplitude of the rescue was
2-fold lower with the RNA-(159-196) template as compared with the
equivalent DNA template (Fig. 3D). No significant rescue of DNA synthesis could be observed with the wt RT in the presence of ATP
or with resistant RT in its absence (Fig. 3B and data not shown).
) Strand DNA Synthesis
) DNA strand synthesis
(Fig. 1A), whereas only dT could be efficiently excised
during initiation (31). As could be expected from the relative
polymerization rates (26, 30), the pyrophosphorolysis of dT was slower
during initiation as compared with elongation (31). However, it could
be easily followed in 1-h time course experiments.
) DNA strand synthesis requires complex
interactions between the primer tRNA
4 s
1) were
identical (within experimental errors) to those determined with the
shorter RNA template, indicating that the rescue of DNA synthesis was
essentially independent of the template length. Again, the low
amplitude of the excision reaction could not be explained by incomplete
annealing of the primer, because non-denaturing electrophoresis showed
that > 98% of ODN-dC-AZT was hybridized to RNA-(1-311) (Fig.
2E, lane 4).




View larger version (18K):
[in a new window]
Fig. 4.
AZT and dT excision and the rescue of DNA
synthesis during initiation of reverse transcription.
A, the rescue of DNA synthesis. The
tRNA 



Two additional controls were performed. In the first one,
tRNA



| |
DISCUSSION |
|---|
|
|
|---|
Even though the selection in the HIV-1 RT gene of mutations conferring resistance toward AZT was first described more than 20 years ago (4-6), the mechanism of action has been unraveled quite recently (21-23), and ATP-dependent excision of AZT by the resistant RT has only been documented for DNA templates. Although the resistance mutations confer a strong resistance toward AZT (4-7), the virus is not insensitive to the drug. Thus, the resistance level might vary considerably, depending on the nature of the primer and template strands.
In this study, we first compared the repair of AZT-terminated primers
with the rescue of DNA synthesis during elongation of the (
) and (+)
DNA strands. We then compared the initiation and elongation steps of
(
) strand DNA synthesis. The results we obtained using a DNA template
and a DNA primer are consistent with previous studies (21-23, 36).
They show that the mutant RT harboring mutations D67N, K70R, T215F, and
K219K can efficiently repair an AZT-terminated DNA primer in the
presence of 3.5 mM ATP. That a weak AZT excision could be
observed with wt RT in the presence of ATP and with resistant RT in its
absence is also consistent with previous data (22). Because we worked
at saturating RT concentrations, the excision of AZT and the repair of
DNA synthesis followed apparent first order kinetics. Our results
showed that the rescue of DNA synthesis is about 3-fold slower than the
repair of the primer, suggesting that the removal of terminal AZT is
significantly inhibited by the next incoming nucleotide. However, this
inhibition is significantly less pronounced than that observed for the
removal of terminal ddA or d4T (22, 36). The in vivo dNTP
concentration varies considerably with the cell type and its activation
state; it ranges from 29 to 150 µM in human H9 T cells
(37), from 3 to 26 µM in activated peripheral blood
mononuclear cells, and from 0.3 to 6 µM in quiescent ones
(38). Thus, the inhibition of AZT excision by the next incoming
nucleotide might be significant in the cell types with the highest dNTP
pool. Noticeably, the most efficient rescue of DNA synthesis should be
observed in the cells with the lowest dNTP pool, i.e. those
cells in which inhibition by AZT is the most efficient (39).
This work is the first to study primer repair and the rescue of DNA synthesis by AZT-resistant RT on an RNA template. We found that these processes take place essentially at the same rate on the DNA and RNA templates. However, we observed an important difference between the two templates; whereas ~80% of a primer was eventually unblocked on a DNA template, only half this amount of primer was repaired when annealed to RNA templates. The origin of this difference is unclear but was not due to incomplete annealing of the primer to the RNA templates. As HIV-1 RT binds DNA/RNA complexes more tightly than DNA/DNA primer-template complexes (24, 40), the stability of the ternary complexes does not appear to be limiting AZT excision on the RNA templates. Because the reaction was much slower than the rate of RT dissociation from and re-association to the primer-template complex (30), our results suggest that the AZT-terminated primer/RNA template adopts two non-interconverting (or slowly converting) conformations, only one being repaired.
Whatever the explanation for the observed difference, its consequence
is that the overall AZT excision by resistant RT is significantly lower
on RNA than on DNA templates. On the other hand, the AZT incorporation
efficiency at a given site by the resistant enzyme is only slightly
reduced during synthesis of the (
) strand, as compared with the (+)
strand (10), and the number of possible incorporation sites are almost
equal. Thus, the difference in AZT excision that we reported in this
study indicates that the inhibition of a resistant virus is more likely to take place during elongation of the (
) strand.
When we used tRNA
The inability of resistant RT to unblock the AZT-terminated primer and
to rescue DNA synthesis during the initiation of reverse transcription
contrasts with the effect of the resistance mutations during the
elongation phase. This lack of primer unblocking was not specific for
the natural tRNA
The inability of resistant RT to remove terminal AZT by ATP lysis during initiation is reminiscent of the inability of wt RT to unblock the AZT-terminated primer by "classical" pyrophosphorolysis (31). However, this study reveals a significant difference between pyrophosphorolysis and ATP lysis. Whereas only AZT was resistant to pyrophosphorolysis by the wt enzyme during the initiation of reverse transcription (31), neither AZT nor dT could be removed via ATP lysis by AZT-resistant RT (this study). Thus, our data suggest that AZT-resistant RT is unable to accommodate ATP in a catalytically competent conformation when bound to the initiation complex.
Our results demonstrate the different effects of resistance
mutations during the initiation and elongation of reverse transcription and during RNA-dependent and DNA-dependent DNA
synthesis. These results highlight the need for detailed studies of
these mutations at each step of the reverse transcription cycle
(initiation of (
) and (+) strand synthesis, RNA- and DNA- dependent
elongation, strand transfers, and termination at the central
termination sequence). Such studies would improve our fundamental
understanding of the resistance mechanisms. They could also point
toward particular steps of the reverse transcription process that would
constitute attractive targets for the development of new antiviral
agents against which the emergence of resistance mutations would be limited.
Our present results obviously indicate that the initiation of reverse
transcription could constitute one such target. Initiation is
intrinsically less efficient than elongation (26, 30, 31), and optimal
initiation requires intricate interactions between viral RNA, RT, and a
cellular component, tRNA
| |
ACKNOWLEDGEMENTS |
|---|
We thank Guillaume Bec and Gérard Keith
for help with the purification of
tRNA
| |
FOOTNOTES |
|---|
* This work was supported by the Agence Nationale de Recherches sur le SIDA, a Biomed II grant from the European Union, and a "Jeunes Equipes" grant from the CNRS (to R. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Present address: Dept. of Medicine, University of Pittsburgh, Pittsburgh, PA 15261.
To whom correspondence should be addressed. Tel.:
33-3-88-41-70-91; Fax: 33-3-88-60-22-18; E-mail: r.marquet@ibmc.u-
strasbg.fr.
Published, JBC Papers in Press, March 18, 2002, DOI 10.1074/jbc.M110836200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
HIV-1, human
immunodeficiency virus type 1;
NRTI, nucleoside reverse transcriptase
inhibitor;
NNRTI, non-nucleoside reverse transcriptase inhibitor;
RT, reverse transcriptase;
AZT, 3'-azido-3'-deoxythymidine;
AZTTP, AZT
5'-triphosphate;
wt, wild type;
dd, dideoxy;
PBS, primer binding site;
3TC,
-L-(
)-2',3'-dideoxy-3'-thyacytidine;
ODN, 18-mer
oligodeoxyribonucleotide complementary to the PBS;
dC, deoxyribocytidine;
d4T, 2',3'didehydro-2', 3'-dideoxythymidine.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Centers for Disease Control and Prevention. (1999) HIV/AIDS Surveillance Report 11, 1-44 |
| 2. |
Carpenter, C. C. J.,
Cooper, D. A.,
Fischl, M. A.,
Gatell, J. M.,
Gazzard, B. G.,
Hammer, S. M.,
Hirsch, M. S.,
Jacobsen, D. M.,
Katzenstein, D. A.,
Montaner, J. S. G.,
Richman, D. D.,
Saag, M. S.,
Schechter, M.,
Schooley, R. T.,
Thompson, M. A.,
Vella, S.,
Yeni, P. G.,
and Volberding, P. A.
(2000)
J. Am. Med. Assoc.
283,
381-391 |
| 3. | Balzarini, J., and De Clercq, E. (1996) Methods Enzymol. 275, 472-502[Medline] [Order article via Infotrieve] |
| 4. |
Kellam, P.,
Boucher, C. A.,
and Larder, B. A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1934-1938 |
| 5. |
Larder, B. A.,
and Kemp, S. D.
(1989)
Science
246,
1155-1158 |
| 6. |
Larder, B. A.,
Darby, G.,
and Richman, D. D.
(1989)
Science
243,
1731-1734 |
| 7. |
Larder, B. A.,
Coates, K. E.,
and Kemp, S. D.
(1991)
J. Virol.
65,
5232-5236 |
| 8. |
Furman, P. A.,
Fyfe, J. A., St.,
Clair, M. H.,
Weinhold, K.,
Rideout, J. L.,
Freeman, G. A.,
Lehrman, S. N.,
Bolognesi, D. P.,
Broder, S.,
Mitsuya, H.,
and Barry, D. W.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8333-8337 |
| 9. | Carroll, S. S., Geib, J., Olsen, D. B., Stahlhut, M., Shafer, J. A., and Kuo, L. C. (1994) Biochemistry 33, 2113-2120[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Kerr, S. G., and Anderson, K. S. (1997) Biochemistry 36, 14064-14070[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Krebs, R., Immendorfer, U., Thrall, S. H., Wohrl, B. M., and Goody, R. S. (1997) Biochemistry 36, 10292-10300[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Lacey, S. F.,
Reardon, J. E.,
Furfine, E. S.,
Kunkel, T. A.,
Bebenek, K.,
Eckert, K. A.,
Kemp, S. D.,
and Larder, B. A.
(1992)
J. Biol. Chem.
267,
15789-15794 |
| 13. |
Gu, Z.,
Gao, Q.,
Fang, H.,
Salomon, H.,
Parniak, M. A.,
Goldberg, E.,
Cameron, J.,
and Wainberg, M. A.
(1994)
Antimicrob. Agents Chemother.
38,
275-281 |
| 14. |
Zhang, D.,
Caliendo, A. M.,
Eron, J. J.,
DeVore, K. M.,
Kaplan, J. C.,
Hirsch, M. S.,
and D'Aquila, R. T.
(1994)
Antimicrob. Agents Chemother.
38,
282-287 |
| 15. |
St. Clair, M. H.,
Martin, J. L.,
Tudor-Williams, G.,
Bach, M. C.,
Vavro, C. L.,
King, D. M.,
Kellam, P.,
Kemp, S. D.,
and Larder, B. A.
(1991)
Science
253,
1557-1559 |
| 16. |
Gao, Q., Gu, Z.,
Parniak, M. A.,
Cameron, J.,
Cammack, N.,
Boucher, C.,
and Wainberg, M. A.
(1993)
Antimicrob. Agents Chemother.
37,
1390-1392 |
| 17. |
Schinazi, R. F.,
Lloyd, R. M., Jr.,
Nguyen, M. H.,
Cannon, D. L.,
McMillan, A.,
Ilksoy, N.,
Chu, C. K.,
Liotta, D. C.,
Bazmi, H. Z.,
and Mellors, J. W.
(1993)
Antimicrob. Agents Chemother.
37,
875-881 |
| 18. |
Tisdale, M.,
Kemp, S. D.,
Parry, N. R.,
and Larder, B. A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5653-5656 |
| 19. |
Canard, B.,
Sarfati, S. R.,
and Richardson, C. C.
(1998)
J. Biol. Chem.
273,
14596-14604 |
| 20. | Arion, D., Kaushik, N., McCormick, S., Borkow, G., and Parniak, M. A. (1998) Biochemistry 37, 15908-15917[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Götte, M.,
Arion, D.,
Parniak, M. A.,
and Wainberg, M. A.
(2000)
J. Virol.
74,
3579-3585 |
| 22. | Meyer, P. R., Matsuura, S. E., Mian, A. M., So, A. G., and Scott, W. A. (1999) Mol. Cell 4, 35-43[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Meyer, P. R.,
Matsuura, S. E., So, A. G.,
and Scott, W. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13471-13476 |
| 24. |
Reardon, J. E.
(1993)
J. Biol. Chem.
268,
8743-8751 |
| 25. | Kerr, S. G., and Anderson, K. S. (1997) Biochemistry 36, 14056-14063[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Lanchy, J. M.,
Keith, G., Le,
Grice, S. F. J.,
Ehresmann, B.,
Ehresmann, C.,
and Marquet, R.
(1998)
J. Biol. Chem.
273,
24425-24432 |
| 27. | Isel, C., Ehresmann, C., Keith, G., Ehresmann, B., and Marquet, R. (1995) J. Mol. Biol. 247, 236-250[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Isel, C., Lanchy, J. M., Le, Grice, S. F. J., Ehresmann, C., Ehresmann, B., and Marquet, R. (1996) EMBO J. 15, 917-924[Medline] [Order article via Infotrieve] |
| 29. | Isel, C., Westhof, E., Massire, C., Le, Grice, S. F. J., Ehresmann, C., Ehresmann, B., and Marquet, R. (1999) EMBO J. 18, 1038-1048[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Lanchy, J. M., Ehresmann, C., Le, Grice, S. F. J., Ehresmann, B., and Marquet, R. (1996) EMBO J. 15, 7178-7187[Medline] [Order article via Infotrieve] |
| 31. |
Rigourd, M.,
Lanchy, J. M., Le,
Grice, S. F. J.,
Ehresmann, B.,
Ehresmann, C.,
and Marquet, R.
(2000)
J. Biol. Chem.
275,
26944-26951 |
| 32. |
Isel, C.,
Ehresmann, C.,
Walter, P.,
Ehresmann, B.,
and Marquet, R.
(2001)
J. Biol. Chem.
276,
48725-48732 |
| 33. | Bénas, P., Bec, G., Keith, G., Marquet, R., Ehresmann, C., Ehresmann, B., and Dumas, P. (2000) RNA (N. Y.) 6, 1347-1355 |
| 34. |
Marquet, R.,
Baudin, F.,
Gabus, C.,
Darlix, J. L.,
Mougel, M.,
Ehresmann, C.,
and Ehresmann, B.
(1991)
Nucleic Acids Res.
19,
2349-2357 |
| 35. |
Isel, C.,
Marquet, R.,
Keith, G.,
Ehresmann, C.,
and Ehresmann, B.
(1993)
J. Biol. Chem.
268,
25269-25272 |
| 36. |
Meyer, P. R.,
Matsuura, S. E.,
Schinazi, R. F., So, A. G.,
and Scott, W. A.
(2000)
Antimicrob. Agents Chemother.
44,
3465-3472 |
| 37. | Frick, L. W., Nelson, D. J., St., Clair, M. H., Furman, P. A., and Krenitsky, T. A. (1988) Biochem. Biophys. Res. Commun. 154, 124-129[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Gao, W. Y.,
Cara, A.,
Gallo, R. C.,
and Lori, F.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
8925-8928 |
| 39. | Arts, E. J., Marois, J. P., Gu, Z., Le, Grice, S. F., and Wainberg, M. A. (1996) J. Virol. 70, 712-720[Abstract] |
| 40. |
Kati, W. M.,
Johnson, K. A.,
Jerva, L. F.,
and Anderson, K. S.
(1992)
J. Biol. Chem.
267,
25988-25997 |
| 41. |
Munis, J. R.,
Kornbluth, R. S.,
Guatelli, J. C.,
and Richman, D. D.
(1992)
J. Gen. Virol.
73,
1899-1906 |
| 42. |
Srivastava, K. K.,
Fernandez-Larsson, R.,
Zinkus, D. M.,
and Robinson, H. L.
(1991)
J. Virol.
65,
3900-3902 |
| 43. | Victorova, L., Sosunov, V., Skoblov, A., Shipytsin, A., and Krayevsky, A. (1999) FEBS Lett. 453, 6-10[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
L. Odriozola, C. Cruchaga, M. Andreola, V. Dolle, C. H. Nguyen, L. Tarrago-Litvak, A. Perez-Mediavilla, and J. J. Martinez-Irujo Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase Inhibit Phosphorolysis and Resensitize the 3'-Azido-3'-deoxythymidine (AZT)-resistant Polymerase to AZT-5'-triphosphate J. Biol. Chem., October 24, 2003; 278(43): 42710 - 42716. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Marchand and M. Gotte Site-specific Footprinting Reveals Differences in the Translocation Status of HIV-1 Reverse Transcriptase: IMPLICATIONS FOR POLYMERASE TRANSLOCATION AND DRUG RESISTANCE J. Biol. Chem., September 12, 2003; 278(37): 35362 - 35372. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||